118 related articles for article (PubMed ID: 21928339)
1. High-throughput assessment of antigen conformational stability by ultraviolet absorption spectroscopy and its application to excipient screening.
Dasnoy S; Le Bras V; Préat V; Lemoine D
Biotechnol Bioeng; 2012 Feb; 109(2):502-16. PubMed ID: 21928339
[TBL] [Abstract][Full Text] [Related]
2. Formulation development of therapeutic monoclonal antibodies using high-throughput fluorescence and static light scattering techniques: role of conformational and colloidal stability.
Goldberg DS; Bishop SM; Shah AU; Sathish HA
J Pharm Sci; 2011 Apr; 100(4):1306-15. PubMed ID: 20960568
[TBL] [Abstract][Full Text] [Related]
3. High-throughput screening of excipients intended to prevent antigen aggregation at air-liquid interface.
Dasnoy S; Dezutter N; Lemoine D; Le Bras V; Préat V
Pharm Res; 2011 Jul; 28(7):1591-605. PubMed ID: 21400018
[TBL] [Abstract][Full Text] [Related]
4. Application of extrinsic fluorescence spectroscopy for the high throughput formulation screening of aluminum-adjuvanted vaccines.
Ausar SF; Chan J; Hoque W; James O; Jayasundara K; Harper K
J Pharm Sci; 2011 Feb; 100(2):431-40. PubMed ID: 20740682
[TBL] [Abstract][Full Text] [Related]
5. Protein-excipient interactions: mechanisms and biophysical characterization applied to protein formulation development.
Kamerzell TJ; Esfandiary R; Joshi SB; Middaugh CR; Volkin DB
Adv Drug Deliv Rev; 2011 Oct; 63(13):1118-59. PubMed ID: 21855584
[TBL] [Abstract][Full Text] [Related]
6. Excipients differentially influence the conformational stability and pretransition dynamics of two IgG1 monoclonal antibodies.
Thakkar SV; Joshi SB; Jones ME; Sathish HA; Bishop SM; Volkin DB; Middaugh CR
J Pharm Sci; 2012 Sep; 101(9):3062-77. PubMed ID: 22581714
[TBL] [Abstract][Full Text] [Related]
7. A rapid, sensitive and economical assessment of monoclonal antibody conformational stability by intrinsic tryptophan fluorescence spectroscopy.
Garidel P; Hegyi M; Bassarab S; Weichel M
Biotechnol J; 2008 Oct; 3(9-10):1201-11. PubMed ID: 18702089
[TBL] [Abstract][Full Text] [Related]
8. Comparison of high-throughput biophysical methods to identify stabilizing excipients for a model IgG2 monoclonal antibody: conformational stability and kinetic aggregation measurements.
Cheng W; Joshi SB; He F; Brems DN; He B; Kerwin BA; Volkin DB; Middaugh CR
J Pharm Sci; 2012 May; 101(5):1701-20. PubMed ID: 22323186
[TBL] [Abstract][Full Text] [Related]
9. High-throughput screening of formulations to optimize the thermal stability of a therapeutic monoclonal antibody.
Niedziela-Majka A; Kan E; Weissburg P; Mehra U; Sellers S; Sakowicz R
J Biomol Screen; 2015 Apr; 20(4):552-9. PubMed ID: 25385011
[TBL] [Abstract][Full Text] [Related]
10. Utility of High Throughput Screening Techniques to Predict Stability of Monoclonal Antibody Formulations During Early Stage Development.
Goldberg DS; Lewus RA; Esfandiary R; Farkas DC; Mody N; Day KJ; Mallik P; Tracka MB; Sealey SK; Samra HS
J Pharm Sci; 2017 Aug; 106(8):1971-1977. PubMed ID: 28456733
[TBL] [Abstract][Full Text] [Related]
11. Application of a high-throughput relative chemical stability assay to screen therapeutic protein formulations by assessment of conformational stability and correlation to aggregation propensity.
Rizzo JM; Shi S; Li Y; Semple A; Esposito JJ; Yu S; Richardson D; Antochshuk V; Shameem M
J Pharm Sci; 2015 May; 104(5):1632-40. PubMed ID: 25757872
[TBL] [Abstract][Full Text] [Related]
12. High-throughput measurement of protein stability in microtiter plates.
Aucamp JP; Cosme AM; Lye GJ; Dalby PA
Biotechnol Bioeng; 2005 Mar; 89(5):599-607. PubMed ID: 15672379
[TBL] [Abstract][Full Text] [Related]
13. Recent trends in stabilising peptides and proteins in pharmaceutical formulation - considerations in the choice of excipients.
Jorgensen L; Hostrup S; Moeller EH; Grohganz H
Expert Opin Drug Deliv; 2009 Nov; 6(11):1219-30. PubMed ID: 19678792
[TBL] [Abstract][Full Text] [Related]
14. Bilateral Effects of Excipients on Protein Stability: Preferential Interaction Type of Excipient and Surface Aromatic Hydrophobicity of Protein.
Wen L; Zheng X; Wang X; Lan H; Yin Z
Pharm Res; 2017 Jul; 34(7):1378-1390. PubMed ID: 28401430
[TBL] [Abstract][Full Text] [Related]
15. Stability challenges in drug discovery.
Di L; Kerns EH
Chem Biodivers; 2009 Nov; 6(11):1875-86. PubMed ID: 19937822
[TBL] [Abstract][Full Text] [Related]
16. Differential scanning fluorimetry: rapid screening of formulations that promote the stability of reference preparations.
Malik K; Matejtschuk P; Thelwell C; Burns CJ
J Pharm Biomed Anal; 2013 Apr; 77():163-6. PubMed ID: 23416371
[TBL] [Abstract][Full Text] [Related]
17. A high throughput platform for understanding the influence of excipients on physical and chemical stability.
Raijada D; Cornett C; Rantanen J
Int J Pharm; 2013 Aug; 453(1):285-92. PubMed ID: 22944300
[TBL] [Abstract][Full Text] [Related]
18. Effects of hydroxypropyl-beta-cyclodextrin on the chemical stability and the aqueous solubility of thalidomide enantiomers.
Alvarez C; Calero J; Menéndez JC; Torrado S; Torrado JJ
Pharmazie; 2008 Jul; 63(7):511-3. PubMed ID: 18717484
[TBL] [Abstract][Full Text] [Related]
19. The effect of solvent environment on the conformation and stability of human polyclonal IgG in solution.
Szenczi A; Kardos J; Medgyesi GA; Závodszky P
Biologicals; 2006 Mar; 34(1):5-14. PubMed ID: 16168667
[TBL] [Abstract][Full Text] [Related]
20. Use of a screening method to determine excipients which optimize the extent and stability of supersaturated drug solutions and application of this system to solid formulation design.
Vandecruys R; Peeters J; Verreck G; Brewster ME
Int J Pharm; 2007 Sep; 342(1-2):168-75. PubMed ID: 17573214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
